Adalimumab in recalcitrant severe psoriasis associated with atopic dermatitis
| Data(s) |
2013
|
|---|---|
| Resumo |
Tumor necrosis factor-α inhibitors may induce various cutaneous side effects including eczematous-like lesions. The management of such side effects can be challenging. Herein, we report a case of a 55-year-old man who had a flare-up and subsequent improvement of atopic dermatitis during treatment of severe psoriasis with adalimumab. |
| Formato |
application/pdf |
| Identificador |
http://boris.unibe.ch/45514/1/yawalkar_case%20re%20dermatol.pdf Yayli, Savas; Irla, Nathalie; Yawalkar, Nikhil (2013). Adalimumab in recalcitrant severe psoriasis associated with atopic dermatitis. Case reports in dermatology, 5(3), pp. 332-335. Karger 10.1159/000356776 <http://dx.doi.org/10.1159/000356776> doi:10.7892/boris.45514 info:doi:10.1159/000356776 info:pmid:24348383 urn:issn:1662-6567 |
| Idioma(s) |
eng |
| Publicador |
Karger |
| Relação |
http://boris.unibe.ch/45514/ |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
Yayli, Savas; Irla, Nathalie; Yawalkar, Nikhil (2013). Adalimumab in recalcitrant severe psoriasis associated with atopic dermatitis. Case reports in dermatology, 5(3), pp. 332-335. Karger 10.1159/000356776 <http://dx.doi.org/10.1159/000356776> |
| Palavras-Chave | #610 Medicine & health |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |
